There are some key clinical and financial use cases already showing their worth – but while innovation around artificial intelligence is happening rapidly, there's risk in moving too quickly, one ...

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations. This guidance represents the view of NICE, arrived at after careful consideration of ...